These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 12549792)

  • 1. Oral erythromycin for treatment of feeding intolerance in preterm infants: a preliminary report.
    Sekteera W; Nuntnarumit P; Supapannachart S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1177-82. PubMed ID: 12549792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants.
    Nuntnarumit P; Kiatchoosakun P; Tantiprapa W; Boonkasidecha S
    J Pediatr; 2006 May; 148(5):600-5. PubMed ID: 16737869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants.
    Mansi Y; Abdelaziz N; Ezzeldin Z; Ibrahim R
    Neonatology; 2011; 100(3):290-4. PubMed ID: 21701222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC
    Neonatology; 2009; 95(2):97-104. PubMed ID: 19218823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin and feeding intolerance in premature infants: a randomized trial.
    Aly H; Abdel-Hady H; Khashaba M; El-Badry N
    J Perinatol; 2007 Jan; 27(1):39-43. PubMed ID: 17036029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC; So KW; Fung KS; Lee CH; Fok TF; Wong E; Wong W; Cheung KL; Cheng AF
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F177-82. PubMed ID: 11320044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates?
    Patole SK; Almonte R; Kadalraja R; Tuladhar R; Muller R; Whitehall JS
    Int J Clin Pract; 2000 Oct; 54(8):504-8. PubMed ID: 11198727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2000; (2):CD001815. PubMed ID: 10796273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2001; (2):CD001815. PubMed ID: 11406010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.
    Ng E; Shah VS
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001815. PubMed ID: 18646077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants.
    ElHennawy AA; Sparks JW; Armentrout D; Huseby V; Berseth CL
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):281-6. PubMed ID: 12960650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants.
    Oei J; Lui K
    Acta Paediatr; 2001 Aug; 90(8):904-8. PubMed ID: 11529540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
    Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
    Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities.
    Gokmen T; Oguz SS; Bozdag S; Erdeve O; Uras N; Dilmen U
    J Perinatol; 2012 Feb; 32(2):123-8. PubMed ID: 21566568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prokinetic therapy for feed intolerance in critical illness: one drug or two?
    Nguyen NQ; Chapman M; Fraser RJ; Bryant LK; Burgstad C; Holloway RH
    Crit Care Med; 2007 Nov; 35(11):2561-7. PubMed ID: 17828038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase 1 trial testing an enteral solution patterned after human amniotic fluid to treat feeding intolerance.
    Barney CK; Purser N; Christensen RD
    Adv Neonatal Care; 2006 Apr; 6(2):89-95. PubMed ID: 16618478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromycin for treatment of feeding intolerance in preterm infants.
    Su BH; Lin HC
    J Pediatr; 2007 Feb; 150(2):e30; author reply e31. PubMed ID: 17236878
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythromycin for treatment of feeding intolerance in preterm infants.
    Mascarenhas S; Lal M
    J Pediatr; 2007 Feb; 150(2):e30-1; author reply e31. PubMed ID: 17236879
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of prophylactic oral erythromycin to improve enteral feeding tolerance in preterm infants: a randomised controlled study.
    Mohammadizadeh M; Ghazinour M; Iranpour R
    Singapore Med J; 2010 Dec; 51(12):952-6. PubMed ID: 21221501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.